Bumper Offer - Urjas oil Just @ Rs. 1
Tamflo 0.8 Mg Capsule, a prescription drug, is manufactured in various forms such as Capsule. Enlarged Prostate are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Tamflo 0.8 Mg Capsule. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Tamflo 0.8 Mg Capsule can also lead to other problems, which have been listed below. These side effects of Tamflo 0.8 Mg Capsule are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Tamflo 0.8 Mg Capsule's effect is Unknown during pregnancy and Unknown for lactating mothers. Warnings related to Tamflo 0.8 Mg Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Tamflo 0.8 Mg Capsule is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Glaucoma as it can result in adverse effects. The section on Tamflo 0.8 Mg Capsule contraindications lists all such conditions.
Besides this, Tamflo 0.8 Mg Capsule may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Tamflo 0.8 Mg Capsule is considered safe while driving, and is addictive.
Tamflo 0.8 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tamflo 0.8 Mg Capsule is used -
Moderate
Mild
Unknown
Is the use of Tamflo 0.8 Mg Capsule safe for pregnant women?
No research has not been done till date on the safety of Tamflo for pregnant women. So its effects on pregnant women are unknown.
Is the use of Tamflo 0.8 Mg Capsule safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Tamflo for breastfeeding women are not known.
What is the effect of Tamflo 0.8 Mg Capsule on the Kidneys?
Tamflo is completely safe for kidneys.
What is the effect of Tamflo 0.8 Mg Capsule on the Liver?
Tamflo does not damage the liver.
What is the effect of Tamflo 0.8 Mg Capsule on the Heart?
There are no any side effects of Tamflo for the heart.
Tamflo 0.8 Mg Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tamflo 0.8 Mg Capsule unless your doctor advises you to do so -
Is this Tamflo 0.8 Mg Capsule habit forming or addictive?
Tamflo 0.8 Mg Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Tamflo 0.8 Mg Capsule does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Tamflo 0.8 Mg Capsule is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Tamflo 0.8 Mg Capsule for mental disorders.
Interaction between Food and Tamflo 0.8 Mg Capsule
You can take Tamflo 0.8 Mg Capsule with food.
Interaction between Alcohol and Tamflo 0.8 Mg Capsule
Taking alcohol with Tamflo 0.8 Mg Capsule can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flomax® (tamsulosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142-143
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1172-1173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flomax® (tamsulosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142-143
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1172-1173
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flomax® (tamsulosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142-143
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1172-1173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Emflaza™ (deflazacort)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flomax® (tamsulosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142-143
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1172-1173